10 research outputs found
EPIdemiology of Surgery-Associated Acute Kidney Injury (EPIS-AKI) : Study protocol for a multicentre, observational trial
More than 300 million surgical procedures are performed each year. Acute kidney injury (AKI) is a common complication after major surgery and is associated with adverse short-term and long-term outcomes. However, there is a large variation in the incidence of reported AKI rates. The establishment of an accurate epidemiology of surgery-associated AKI is important for healthcare policy, quality initiatives, clinical trials, as well as for improving guidelines. The objective of the Epidemiology of Surgery-associated Acute Kidney Injury (EPIS-AKI) trial is to prospectively evaluate the epidemiology of AKI after major surgery using the latest Kidney Disease: Improving Global Outcomes (KDIGO) consensus definition of AKI. EPIS-AKI is an international prospective, observational, multicentre cohort study including 10 000 patients undergoing major surgery who are subsequently admitted to the ICU or a similar high dependency unit. The primary endpoint is the incidence of AKI within 72 hours after surgery according to the KDIGO criteria. Secondary endpoints include use of renal replacement therapy (RRT), mortality during ICU and hospital stay, length of ICU and hospital stay and major adverse kidney events (combined endpoint consisting of persistent renal dysfunction, RRT and mortality) at day 90. Further, we will evaluate preoperative and intraoperative risk factors affecting the incidence of postoperative AKI. In an add-on analysis, we will assess urinary biomarkers for early detection of AKI. EPIS-AKI has been approved by the leading Ethics Committee of the Medical Council North Rhine-Westphalia, of the Westphalian Wilhelms-University Münster and the corresponding Ethics Committee at each participating site. Results will be disseminated widely and published in peer-reviewed journals, presented at conferences and used to design further AKI-related trials. Trial registration number NCT04165369
The conductive polyaniline/poly(ethylene terephthalate) composite fabrics
Conductive composite fabrics were prepared by chemical polymerization of aniline on poly(ethylene terephthalate) (PET) fabrics in the aqueous hydrochloride acid solutions using potassium dichromate as the oxidant. The effect of the polymerization conditions such as temperature, oxidant, aniline and hydrochloride acid concentrations was investigated on the electrical surface resistance and polyaniline (PAn) content of PAn/PET composite fabrics. The maximum PAn content and the lower electrical resistance of composite fabrics were observed at the HCl concentrations of 0.25 M and 1.5 M, respectively. The electrical surface resistance of the PAn/PET composite fabrics was decreased under vacuum five-fold more than the ones kept under in air. The properties of PAn/PET composite fabrics such as density, diameter and moisture regain were also investigated in comparison with the those of pure PET. The conductive composite fabrics were characterized by surface resistance, FTIR and TGA techniques
Depression, Anxiety and Quality of Life of Family Caregivers of Patients with Type 2 Diabetes
Women in Turkish family businesses: drivers, contributions and challenges
The number and importance of women in family businesses have increased in the recent years. This is reflected in the growing academic and practitioner interest in the topic. In this paper, we have explored the role of women in family business in the context of Turkey by examining the key drivers for their active involvement, their contribution and the challenges they face. The conceptual framework of the article presents key drivers and challenges identified in the extant literature and introduces additional angles on the problematisation of the topic, mainly issues of succession, conflict and balance of work-life relationships. Drawing on empirical material collected through semi-structured interviews with participant Turkish women, we have highlighted importance of cultural dynamics in analysing drivers, contributions and challenges
Assessing the soil-structure interaction effects by direct method on the out-of-plane behavior of masonry structures (case study: Arge-Tabriz)
Use of Conditional Mean Spectra for Seismic Evaluation of RC Building Considering Soil Effects
EPIdemiology of Surgery-Associated Acute Kidney Injury (EPIS-AKI): Study protocol for a multicentre, observational trial
Introduction More than 300 million surgical procedures are performed each year. Acute kidney injury (AKI) is a common complication after major surgery and is associated with adverse short-term and long-term outcomes. However, there is a large variation in the incidence of reported AKI rates. The establishment of an accurate epidemiology of surgery-associated AKI is important for healthcare policy, quality initiatives, clinical trials, as well as for improving guidelines. The objective of the Epidemiology of Surgery-associated Acute Kidney Injury (EPIS-AKI) trial is to prospectively evaluate the epidemiology of AKI after major surgery using the latest Kidney Disease: Improving Global Outcomes (KDIGO) consensus definition of AKI. Methods and analysis EPIS-AKI is an international prospective, observational, multicentre cohort study including 10 000 patients undergoing major surgery who are subsequently admitted to the ICU or a similar high dependency unit. The primary endpoint is the incidence of AKI within 72 hours after surgery according to the KDIGO criteria. Secondary endpoints include use of renal replacement therapy (RRT), mortality during ICU and hospital stay, length of ICU and hospital stay and major adverse kidney events (combined endpoint consisting of persistent renal dysfunction, RRT and mortality) at day 90. Further, we will evaluate preoperative and intraoperative risk factors affecting the incidence of postoperative AKI. In an add-on analysis, we will assess urinary biomarkers for early detection of AKI. Ethics and dissemination EPIS-AKI has been approved by the leading Ethics Committee of the Medical Council North Rhine-Westphalia, of the Westphalian Wilhelms-University Münster and the corresponding Ethics Committee at each participating site. Results will be disseminated widely and published in peer-reviewed journals, presented at conferences and used to design further AKI-related trials. Trial registration number NCT04165369.